Registro:

Referencias:

• Lambert, J.J., Peters, J.A., Harney, S.C., Belelli, D., Steroid Modulation of GABAA Receptors (2001) Handbook of Experimental Pharmacology, 150, pp. 117-140. , Pharmacology of GABA and Glycine Neurotransmission; Möhler, H. Ed, Springer: Berlin
• Lambert, J.J., Belelli, D., Peden, D.R., Vardy, A.W., Peters, J.A., Neurosteroid modulation of GABAA receptors (2003) Prog. Neurobiol, 71, pp. 67-80
• Warner, M., Gustafsson, J.A., Nongenomic effects of estrogen. Why all the uncertainty? (2006) Steroids, 71, pp. 91-95
• Whiting, P. J. GABA-A receptor subtypes in the brain, a paradigm for CNS drug discovery. Drug DiscoVery Today 2003, 8, 445-450; Hamilton, N.M., Interaction of steroids with GABAA receptor (2002) Curr. Top. Med. Chem, 2, pp. 887-902
• Belelli, D., Lambert, J.J., Neurosteroids, endogenous regulators of the GABAA receptor (2005) Nat. Rev. Neurosci, 6, pp. 565-575
• Akk, G., Covey, D.F., Evers, A.S., Steinbach, J.H., Zorumski, C.F., Mennerick, S., Mechanisms of neurosteroid interactions with GABAA receptors (2007) Pharmacol. Ther, 116, pp. 35-57
• Harrison, N.L., Majewska, M.D., Harrington, J.W., Barker, J.L., Structure-activity-relationships for steroid interaction with the gammaaminobutyric acidA receptor complex (1987) J. Pharmacol. Exp. Ther, 241, pp. 346-353
• Akk, G., Shu, H.J., Wang, C., Steinbach, J.H., Zorumski, C.F., Covey, D.F., Mennerick, S., Neurosteroid access to the GABAA receptor (2005) J. Neurosci, 25, pp. 11605-11613
• Reddy, D.S., Anticonvulsant activity of the testosterone-derived neurosteroid 3α-androstanediol (2004) NeuroReport, 15, pp. 515-518
• Li, W.J., Jin, X.C., Covey, D.F., Steinbach, J.H., Neuroactive steroids and human recombinant rho 1 GABA(C) receptors (2007) J. Pharmacol. Exp. Ther, 323, pp. 236-247
• Akk, G., Bracamontes, J.R., Covey, D.F., Evers, A., Dao, T., Steinbach, J.H., Neuroactive steroids have multiple actions to potentiate GABAA receptors (2004) J. Physiol, 558, pp. 59-74
• Hosie, A.M., Wilkins, M.E., da Silva, H.M.A., Smart, T.G., Endogenous neurosteroids regulate GABAA receptors via two discrete transmembrane sites (2006) Nature, 444, pp. 486-489
• Nin, M.S., Salles, F.B., Azeredo, L.A., Frazon, A.P.G., Gomez, R., Barros, H.M.T., Antidepressant effect and changes of GABA(A) receptor gamma 2 subunit mRNA after hippocampal administration of allopregnanolone in rats (2008) J. Psychopharmacol, 22, pp. 477-485
• Maguire, J., Mody, I., Neurosteroid synthesis-mediated regulation of GABAA receptors, relevance to the ovarian cycle and stress (2007) J. Neurosci, pp. 2155-2162
• Marx, C.E., Stevens, R.D., Shampine, L.J., Uzunova, V., Trost, W.T., Butterfield, M.I., Massing, M.W., Lieberman, J.A., Neuroactive steroids are altered in schizophrenia and bipolar disorder, relevance to pathophysiology and therapeutics (2006) Neuropsychopharmacology, 31, pp. 1249-1263
• Bialer, M., The pharmacokinetics and interactions of new antiepileptic drugs. An overview (2005) Ther. Drug Monit, 27, pp. 722-726
• Death, A.K., McGrath, K.C.Y., Handelsman, D.H., Valproate is an anti-androgen and anti-progestin (2005) Steroids, 70, pp. 946-953
• Alvarez, L.D., Veleiro, A.S., Baggio, R.F., Garland, M.T., Edelsztein, V.C., Coirini, H., Burton, G., Synthesis and GABAA receptor activity of oxygen-bridged neurosteroid analogues (2008) Bioorg. Med. Chem, 16, pp. 3831-3838
• Bian, X.Q., Li, S.S., Geng, X., Liu, L.H., Xie, Z.Y., Wang, C., Synthesis of the neuroactive steroid antagonist 17-phenyl-5alphaandrost-16-en- 3alpha-ol by a palladium-catalysed coupling reaction (2008) J. Chem. Res., Synop, 7, pp. 422-424
• Zeng, C.M., Manion, B.D., Benz, A., Evers, A.S., Zorumski, C.F., Mennerick, S., Covey, D.F., Neurosteroid analogues. 10. The effect of methyl group substitution at the C-6 and C-7 positions on the GABA modulatory and anesthetic actions of (3alpha,5alpha)- and (3alpha,5beta)-3-hydroxypregnan-20- one (2005) J. Med. Chem, 48, pp. 3051-3059
• (2009) Journal of Medicinal Chemistry, 52 (7). , SlaVíkoVá et al
• Carter, R.B., Wood, P.L., Wieland, S., Hawkinson, J.E., Belelli, D., Lambert, J.J., White, H.S., Gee, K.W., Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor (1997) J. Pharmacol. Exp. Ther, 280, pp. 1284-1295
• Slavíková, B., Kasal, A., Uhlířová, L., Kršiak, M., Chodounská, H., Kohout, L., Suppressing aggressive behavior with analogs of allopregnanolone (epalon) (2001) Steroids, 66, pp. 99-105
• Huang, R.Q., Dillon, G.H., Functional analysis of GABA receptors in nucleus tractus solitarius A neurons from neonatal rats (2001) Brain Res, 921, pp. 183-194
• Š íša, M.; Hniličková, J.; Swaczynová, J.; Kohout, L. Syntheses of new androstane brassinosteroids with 17β-ester groupssbutyrates, heptafluorobutyrates, and laurates. Steroids 2005, 70, 755-762; Kasal, A., 6-Substituted derivatives of 7-norallopregnanolone (2000) Tetrahedron, 56, pp. 3559-3565
• Kasal, A., Matyáš, L., Buděší nský, M., Neurosteroid analogues, synthesis of 6-aza-allopregnanolone (2005) Tetrahedron, 61, pp. 2269-2278
• Suñol, C., García, D.A., Bujons, J., Krištofí ková, Z., Matyáš, L., Babot, Z., Kasal, A., Activity of analogues of neurosteroids on the GABAA receptor in primary neuronal cultures (2006) J. Med. Chem, 49, pp. 3225-3234
• Löscher, W., Potschka, H., Drug resistance in brain diseases and the role of drug efflux transporters (2005) Nat. Rev. Neurosci, 6, pp. 591-602
• Wolka, A.M., Huber, J.D., Davis, T., Pain and the blood-brain barrier, obstacles to obstacles to drug delivery (2003) AdV. Drug DeliVery Rev, 55, pp. 987-1006
• Reddy, D.S., Castaneda, D.C., O'Malley, B.W., Rogawski, M.A., Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice (2004) J. Pharmacol. Exp. Ther, 310, pp. 230-239
• Park, K. K.; Ko, D. H.; You, Z.; Heiman, A. S.; Lee, H. J. Synthesis and pharmacological evaluations of new steroidal anti-inflammatory antedrugs, 9α-fluoro-11β,17α,21-trihydroxy-3,20-dioxo-pregna-1, 4-diene-16α-carboxylate (FP16CM) and its derivatives. Steroids 2006, 71, 83-89; Mitsukuchi, M., Ikemoto, T., Taguchi, M., Higuchi, S., Abe, S., Yasui, H., Hatayama, K., Sota, K., Synthesis of 17α-acyloxy-9α-fluoro- 11β-hydroxy-16β-methyl-1,4-pregnadiene-3,20-dione 21-thio derivatives and related compounds (1989) Chem. Pharm. Bull, 37, pp. 3286-3293
• Alexander, N.J., Kim, H.K., Blye, R.R., Blackmore, P.F., Steroid specificity of the human sperm membrane progesterone receptor (1996) Steroids, 61, pp. 116-125
• Selye, H., Pharmaco-chemical interrelations among catatoxic steroids (1970) Rev. Can. Biol, 29, pp. 49-102
• Slavíková, B., Kasal, A., Epalons, synthesis of new 16α-carboxymethyl derivatives (1999) Collect. Czech. Chem. Commun, 64, pp. 1479-1486
• Slavíková, B., Kasal, A., Chodounská, H., Krištofíková, Z., 3α-Fluoro analogues of "allopregnanolone" and their binding to GABAA receptors (2002) Collect. Czech. Chem. Commun, 67, pp. 30-46
• Mareš, P., Haugvicová, R., Kasal, A., Action of two neuroactive steroids against motor seizures induced by pentetrazol in rats during ontogeny (2006) Physiol. Res, 55, pp. 437-444
• Mareš, P., Mikulecká, A., Haugvicová, R., Kasal, A., Anticonvulsant action of allopregnanolone in immature rats (2006) Epilepsy Res, 70, pp. 110-117
• Mazu, R.H., Cella, J.A., 16-Substituted steroids (1959) Tetrahedron, 7, pp. 130-137
• Kano, T., Tanaka, Y., Maruoka, K., Organocatalytic oxy-Michael addition of alcohols to α,β-unsaturated aldehydes (2006) Tetrahedron Lett, 47, pp. 3039-3041
• Marker, R.E., 17-Hydroxy-20-ketopregnanes from steroidal sapogenins (1949) J. Am. Chem. Soc, 71, pp. 4149-4151
• Fukushima, D.K., Gallagher, T.F., The action of methanolic KOH on a δ16-20-ketosteroid, isolation of 3β-acetoxy-16-methoxy- δ5-pregnen-20-one (1950) J. Am. Chem. Soc, 72, pp. 2306-2306
• Nising, C.F., Brase, S., The oxa-Michael reaction: From recent developments to applications in natural product synthesis (2008) Chem. Soc. Rev, 37, pp. 1218-1228
• Jászay, Z.M., Németh, G., Pham, T.S., Petneházy, I., Grün, A., Töke, L., Catalytic enantioselective Michael addition in the synthesis of α-aminophosphonates (2005) Tetrahedron: Asymmetry, 16, pp. 3837-3840
• Sharma, U., Bora, U., Boruah, R.C., Sandhu, J.S., Alumina-promoted fast solid-phase Michael addition of enamines with conjugated enones under microwave irradiation (2002) Tetrahedron Lett, 43, pp. 143-145
• Hajos, Z. G.; Parrish, D. R. Synthesis and conversion of 2-methyl-2-(3-oxobutyl)-1,3-cyclopentanedione to isomeric racemic ketols of [3.2.1]bicyclooctane of perhydroindan series. J. Org. Chem. 1974, 39, 1612-1615; Kisanga, P.B., Ilankumaran, P., Fetterly, B.M., Verkade, J.G., P(RNCH2CH2)3N, efficient 1,4-addition catalyst (2002) J. Org. Chem, 67, pp. 3555-3560
• Murtagh, J.E., McCooey, S.H., Connon, S.J., Novel amine-catalysed hydroalkoxylation reactions of activated alkenes and alkynes (2005) Chem. Commun, pp. 227-229
• Wabnitz, T.C., Spencer, J.B., A general, Brønsted acid-catalyzed hetero-Michael addition of nitrogen, oxygen, and sulfur nucleophiles (2003) Org. Lett, 5, pp. 2141-2144
• Farnworth, M.V., Cross, M.J., Louie, J., Rhodium-catalyzed addition of alcohols to terminal enones (2004) Tetrahedron Lett, 45, pp. 7441-7443
• Jenner, G., Effect of pressure on sterically congested cyanoalkylation reactions of alcohols (2002) Tetrahedron, 58, pp. 4311-4317
• Bowers, A., Denot, E., Becerra, R., The abnormal addition of I-F to δ5-steroids (1960) J. Am. Chem. Soc, 82, pp. 4007-4012
• Danilewicz, J.B., Klyne, W., Side-chain-substituted 5α-pregnanes not carrying substituents in the phenanthrene nucleus (1962) J. Chem. Soc, pp. 4950-4957
• Kirk, D.N., The circular dichroism of strained, bridge-ring, and other ketones (1977) J. Chem. Soc., Perkin. Trans. 1, pp. 2122-2148
• Wilkins, M.E., Hosie, A.M., Smart, T.G., Proton modulation of recombinant GABA(A) receptors, influence of GABA concentration and the beta subunit TM2-TM3 domain (2005) J. Physiol. (London), 567, pp. 365-377
• Moreira, V.M.A., Vasaitis, T.S., Guo, Z., Njar, V.C.O., Salvador, J.A.R., Synthesis of novel C17 steroidal carbamates. Studies on CYP17 action, androgen receptor binding and function, and prostate cancer cell growth (2008) Steroids, 73, pp. 1217-1227
• Dieckhaus, C.M., Roller, S.G., Santos, W.L., Sofia, R.D., Macdonald, T.L., Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metabolite (2001) Chem. Res. Toxicol, 14, pp. 511-516
• Kapetanovic, I.M., Torchin, C.D., Thompson, C.D., Miller, T.A., McNeilly, P.J., MacDonald, T.L., Kupferberg, H.J., Strong, J.M., Potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro (1998) Drug Metab. Dispos, 26, pp. 1089-1095
• Popovic, M., Nierkens, S., Pieters, R., Uetrecht, J., Investigating the role of 2-phenylpropenal in felbamate-induced idiosyncratic drug reactions (2004) Chem. Res. Toxicol, 17, pp. 1568-1576
• Anderson, R.A., Baillie, T.A., Axelson, M., Cronholm, T., Sjoevall, K., Sjoevall, J., (1990) Steroids, 55, pp. 443-457
• Bladon, P., The Michael reaction of 3β-acetoxypregna-5,16-dien-20- one (1958) J. Chem. Soc, 372, pp. 3-26
• Bandyopadhyay, P., Janout, V., Zhang, L., Regen, S.L., Ion conductors derived from cholic acid and spermine. Importance of facial hydrophilicity on Na+ transport and membrane selectivity (2001) J. Am. Chem. Soc, 123, pp. 7691-7696
• Wall, M.E., Kenney, H.E., Rothman, E.S., Conversion of steroidal sapogenin to δ16-20-ketopregnanes (1955) J. Am. Chem. Soc, 77, pp. 5665-5668

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------